Success

Alert

Please select a Day.

Info

Sun Pharmaceutical Industries Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

Follow Following

Score

79/100

1,779.70

2.30 (0.13%)

As on 21 Nov, 2025 | 03:58

Open Trading A/c

Day Range

1773.70

1787.40

L H

52 Week Range

1548.00

1910.00

L H

Volume

2,199,311

* BSE Market Depth (21 Nov 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
25	1779.05	1783.75	15
1	1779.00	1783.80	10
222	1778.55	1784.00	20
222	1778.50	1785.50	3
232	1778.15	1786.00	93
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Score

79/100

1,779.80

1.95 (0.11%)

As on 21 Nov, 2025 | 04:01

Open Trading A/c

Day Range

1773.40

1787.75

L H

52 Week Range

1547.25

1910.00

L H

Volume

38,089

* BSE Market Depth (21 Nov 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
25	1779.05	1783.75	15
1	1779.00	1783.80	10
222	1778.55	1784.00	20
222	1778.50	1785.50	3
232	1778.15	1786.00	93
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Score

79/100

-- (--%)

As on --

Day Range

L H

Open Interest Analysis

Long Unwinding

(OI , PRICE )

See Historical Trend

Volume

Bid / Ask

Advance Chart

Score

79/100

-- (--%)

As on --

Day Range

L H

Moneyness

Volume

Bid / Ask

Advance Chart

Sun Pharma

1,779.70

2.30(0.13%)

NSE

#KnowBeforeYouInvest
Forecast

MC Essentials

65% Pass

MC Technicals

This represents current trend.Click here for disclaimer.

Trend

MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials

Ownerships

Industry Comparison

Others

Overview
Chart
Forecast
MC Insights
MC Technicals
Chart Patterns
Scans
Price & Volume
Seasonality Analysis
News
Forum
Research
Deals
Corp Action
Financials
Shareholding
Financials Shareholding Peers About

Open	1,778.00
Previous Close	1,777.40
Volume	2,199,311.00
Value (Lacs)	39,141.14
VWAP	1,779.35
Beta	0.68 0.66
Mkt Cap (Rs. Cr.)	427,010

High	1,787.40
Low	1,773.70
UC Limit	1,955.10
LC Limit	1,599.70
52 Week High	1,910.00
52 Week Low	1,548.00
Face Value	1.00

All Time High	1,960.35
All Time Low	7.15
20D Avg Volume	1,731,953
20D Avg Delivery(%)	57.28
Book Value Per Share	300.99
Dividend Yield	0.90

TTM EPS See historical trend	43.55 (-5.47% YoY)
TTM PE See historical trend	40.87 (Average PE)
P/B See historical trend	5.92 (High P/B)
Sector PE	39.94

Open	- -
Previous Close	- -
Volume	- -
Value(lacs)	- -

High	- -
Low	- -
ATP	- -
Spot	- -

OI	- -
OI Chg(Chg%)	- -
Lot Size	- -
Contracts Traded	- -

Roll Over %	- -
Roll Over Cost	- -
MWPL	- -

Advanced Chart

Click here to expand

*Delayed by 20 seconds.

Forecast

Share Price Forecast

Earnings Forecast

Actuals Estimates

ANNUALLY

(Rs.)

EPS
Net Profit
Revenue

Valuations

Consensus Recommendations

Buy
Outperform
Hold
Underperform
Sell

Hits/Misses

QUARTERLY (Rs.)

EPS
Net Profit
Revenue

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

MC Insights

Stock Score

79/100

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Get detailed analysis with Moneycontrol Stock Insights.

Price

6.82% away from 52 week high

Financials

Piotroski Score

indicates

Industry Comparison

Market Cap - Market Leader

Shareholding Pattern

Promoter holding remains unchanged at 54.48% in Sep 2025 qtr.

MC Technicals

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages

Days
5	- -
10	- -
20	- -
50	- -
100	- -
200	- -

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Moving Averages

Days

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Moving Averages

Days

CHART PATTERNS ^{Super PRO}

Price and Volume

Price Performance

1 Week		--%
1 Month		--%
3 Months		--%
YTD		--%
1 Year		--%
3 Years		--%

Volume Analysis

Volume
Delivery

SEASONALITY ANALYSIS

9 out of 17 years Sun Pharmaceutical Industries has given positive returns in November.

Month	Max. Positive Change(%)	Avg. Positive Change(%)	Max. Negative Change(%)	Avg. Negative Change(%)	Average Change(%)
November	12.61% (2023)	5.80%	-17.98% (2015)	-7.02%	-0.23%

Seasonality Analysis

News

Trade Spotlight: How should you trade Sun Pharma, PB Fintech, Titan, Coforge, ICICI Lombard, Nestle, and others on November 20?

Nov 20 2025 02:52 AM

AstraZeneca partners with Sun Pharma to expand access to hyperkalaemia treatment Lokelma Nov 17 2025 05:50 PM
Trade Spotlight: How should you trade Tech Mahindra, Aurobindo Pharma, Garden Reach, Bharat Forge, M&M, and others on November 12? Nov 12 2025 04:15 AM
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher Nov 11 2025 02:19 PM
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y Nov 11 2025 11:29 AM

Earning + See More

Forum

Community Sentiments

100% BUY
0% SELL
0% HOLD

100%

of moneycontrol users recommend buying Sun Pharma

What's your call on Sun Pharma today?

Read 1 investor views

BUY SELL HOLD

Dream_Nifty1389
Sun Pharma
Follow

12 hrs ago

Select Right Stock s.now.12.9.7868390.me For Trading And Get s.now.12.9.7868390.me Jackpot Profit Everyday From Market With s.now.12.9.7868390.me View more

Posted by : Dream_Nifty1389
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Select Right Stock s.now.12.9.7868390.me For Trading And Get s.now.12.9.7868390.me Jackpot Profit Everyday From Market With s.now.12.9.7868390.me
  
  Repost Cancel
You will now receive notification when someone reply to this message.
raju20089116
Sun Pharma
Follow

2 days ago

huge buying tmrw sunpharma will touch 1830 View more

Posted by : raju20089116
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  huge buying tmrw sunpharma will touch 1830
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

1 days ago

Sponsored Post
Your Investment Portfolio Deserves a Fixed Return for Balance 9.75% IIFL SAMASTA FINANCE LIMITED 16/Jul/2028 ✔️ Coupon: 9.75% ✔️ Rating: CRISIL AA- Stable ✔️ Tenor: 2y 7m (Maturity: 16/Jul/2028) Senior Secured Bond | NBFC Bonds | High Return Bond | Listed Strengthen your portfolio with a high-yield instrument that prioritises safety, stability, and predictable income. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJHbVp3PT0=/975-iifl-samasta-finance-limited-16jul2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Your Investment Portfolio Deserves a Fixed Return for Balance 9.75% IIFL SAMASTA FINANCE LIMITED 16/Jul/2028 ✔️ Coupon: 9.75% ✔️ Rating: CRISIL AA- Stable ✔️ Tenor: 2y 7m (Maturity: 16/Jul/2028) Senior Secured Bond | NBFC Bonds | High Return Bond | Listed Strengthen your portfolio with a high-yield instrument that prioritises safety, stability, and predictable income. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJHbVp3PT0=/975-iifl-samasta-finance-limited-16jul2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Broker Research

05 Nov, 2025

Prabhudas Lilladher

Reco Price 1692.75

Target Price 1875

06 Nov, 2025

Emkay Global Financial Services

Reco Price 1685.75

Target Price 2000

06 Nov, 2025

Motilal Oswal

Reco Price 1685.75

Target Price 1960

23 Sep, 2025

Motilal Oswal

Reco Price 1631.15

Target Price 1960

31 Jul, 2025

Motilal Oswal

Reco Price 1705.55

Target Price 1960

01 Aug, 2025

Prabhudas Lilladher

Reco Price 1629.05

Target Price 1875

REFINITIV Report

18 Nov, 2025

Gqg Partners Emerging Markets Equity Cit

Qty 1446414

Price 1763.9

% Traded 0.06

18 Nov, 2025

Reliance Trust Institutional Retirement Trust Series Twelve

Qty 1446414

Price 1763.9

% Traded 0.06

09 Oct, 2025

Goldman Sachs (singapore) Pte - Odi

Qty 148233

Price 1631.6

% Traded 0.01

09 Oct, 2025

Goldman Sachs Bank Europe Se - Odi

Qty 148233

Price 1631.6

% Traded 0.01

14 Jul, 2025

The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828

Qty 309391

Price 1672

% Traded 0.01

14 Jul, 2025

The Mtbj Ltd.as Trst For Government Pension Investment Fund Mtbj400045849

Qty 309391

Price 1672

% Traded 0.01

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

No Data For Bulk Deals.

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

Corporate Action

+ See More

Date	Agenda

+ See More

Ex-Date	Type	Dividend (Rs)

+ See More

Announcement Date	Ex-Bonus	Ratio

+ See More

Ex-Split	Old FV	New FV

+ See More

Ex-Right	Ratio	Premium

+ See More

Date	Agenda

+ See More

Financials

Consolidated
Standalone

Quarterly Annually

(Rs. Cr)

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

(Rs. Cr)

Revenue

Net Profit

BVPS

Debt to Equity

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

Shareholding

Summary

See Top Holdings

Trend

PEERS

Company Name	Price	% Chg	MCap(Cr)	TTM PE	P/B	ROE(%)	1 Yr Perform(%)	Net Profit(Rs.)	Net Sales(Rs.)	Debt to Equity
Sun Pharma	1,779.70	0.13	427,009.64	40.87	5.91	15.13	-0.02	10,980	52,578	0.03
Divis Labs	6,373.00	-1.38	169,183.13	68.08	11.30	14.63	6.62	2,191	9,360	0.00
Torrent Pharma	3,686.50	-0.94	124,767.91	58.30	16.63	25.17	18.84	1,911	11,516	0.40
Cipla	1,511.80	-1.14	122,118.85	22.44	3.91	16.90	3.16	5,291	27,547	0.00
Dr Reddys Labs	1,243.90	-0.38	103,818.53	17.99	3.09	16.85	4.06	5,703	32,643	0.12

+ See More

About the Company

Sun Pharmaceutical Inds. Ltd is an international speciality pharma company.The company also makes active pharmaceutical ingredients. In branded markets, their products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.The company is engaged in manufacturing of product in the following therapy areas:CNS disorders,Cardiology,Diabetes and Metabolic disorders,Gastroenterology,Ophthalmology ,Oncology,Pain,Allergy, Asthma and Inflammation and Gynecological.

Registered Office
- Address
  Sun Pharma Advanced Research Centre (SPA,Tandalja,,
- City
  Vadodra
- State
  Gujarat
- Pin Code
  390012
- Tel. No.
  0265-6615500
- Fax No.
  0265-2354897
- Email
  secretarial@sunpharma.com
- Internet
  http://www.sunpharma.com
Registrars
- Address
  C 101, 247 Park, L.B.S. Marg, Vikhroli (West),,
- City
  Mumbai 400083
- State
  Maharashtra
- Tel. No.
  022-49186270, 49186200
- Fax No.
  022-49186060
- Email
  rnt.helpdesk@linkintime.co.in
- Internet
  http://www.linkintime.co.in
Management
- Dilip S Shanghvi
  Chairman & Managing Director
- Aalok D Shanghvi
  Whole Time Director & COO
- Vidhi D Shanghvi
  Whole Time Director
- Sudhir V Valia
  Non Exe.Non Ind.Director
- Pawan Goenka
  Lead Independent Director
+ See More
Included In
- BSE 100
  Yes
- BSE 200
  Yes
- SENSEX
  Yes
- CNX MIDCAP 200
  No
- NIFTY 50
  Yes
- BSE 500
  Yes
- Nifty 200
  Yes
Details
- BSE:
  524715
- NSE:
  SUNPHARMA
- Series
  EQ
- ISIN
  INE044A01036